A microscopia holográfica digital (DHM) na medicina utiliza tecnologia ótica avançada para captar e analisar informação holográfica de espécimes biológicos. Ao contrário da microscopia tradicional, o DHM regista informação de intensidade e fase, permitindo imagens tridimensionais com resolução à escala nanométrica. Esta técnica não invasiva facilita o exame detalhado de células e tecidos vivos, permitindo a monitorização e análise em tempo real. As aplicações do DHM incluem a dinâmica celular, estudos de patologia e desenvolvimento de medicamentos, oferecendo informações valiosas para a investigação e diagnóstico médico.
Aceda ao relatório completo em https://www.databridgemarketresearch.com/reports/north-america-digital-holographic-microscopy-in-medical-market
A Data Bridge Market Research analisa que a microscopia holográfica digital no mercado médico da América do Norte , que era de 33,98 milhões de dólares em 2021, deverá atingir 353,23 milhões de dólares até 2029, com um CAGR de 34,00% durante o período previsto de 2022 a 2029. Um ambiente regulatório favorável com estruturas e diretrizes bem definidas acelera a aceitação e integração da microscopia holográfica digital na investigação e diagnóstico médico, promovendo a inovação e fiabilidade em aplicações de saúde.
Principais conclusões do estudo
Espera-se que a elevada utilização de microscopia holográfica digital sem lentes na área médica impulsione a taxa de crescimento do mercado
A ampla utilização da microscopia holográfica digital sem lentes na medicina é impulsionada pela sua compatibilidade com instrumentos compactos e acessíveis, ideais para avaliações microfluídicas e deteção de doenças no local de prestação de cuidados. Esta abordagem sem lentes reproduz digitalmente pequenas imagens de espécimes sem lentes tradicionais, resultando em dispositivos mais leves, mais pequenos e económicos. O paradigma de imagem sem lente facilita imagens de alto rendimento e alta resolução através de ferramentas portáteis e económicas. Espera-se que o crescimento previsto na utilização da microscopia holográfica digital sem lentes na medicina impulsione significativamente o mercado da microscopia holográfica digital no setor médico.
Âmbito do Relatório e Segmentação de Mercado
Métrica de Reporte
|
Detalhes
|
Período de previsão
|
2022 a 2029
|
Ano base
|
2021
|
Anos Históricos
|
2020 (personalizável para 2014-2019)
|
Unidades quantitativas
|
Receita em milhões de dólares americanos, volumes em unidades, preços em dólares americanos
|
Segmentos abrangidos
|
Type (Label-Free Interferometric Technique and Quantitative Phase Image), Offering (Hardware and Software), Process Type (Digital Recording and Reconstruction), Configuration (Gabor Holography (Inline Holography), Image Plane Holography, Fresnel Holography, Fourier Holography, and Off-Axis Holography), Application (Quantitative Study of Cellular Dynamics, 3-D Imaging, Diabetics Diagnosis, Visualization of Drug-Induced Morphology Changes, Resolve Neuronal Network Activity and Others), End User (Hospitals and Clinics, Pharmaceutical and Biotechnological Companies, Academic Medical Centers and Research Organizations)
|
Countries Covered
|
U.S., Canada and Mexico in North America
|
Market Players Covered
|
Lyncée Tec SA (Switzerland), Holoxica Ltd (U.K.), RealView Imaging Ltd (Israel), EON Reality (U.S.), Leia Inc. (U.S.), Geola (Lithuania), Holmarc Opto-Mechatronics Ltd. (India), Ovizio (Belgium), Realfiction (Sweden), ZEISS International (Germany), Jasper Display Corp.(U.S.), Trimos (Switzerland)
|
Data Points Covered in the Report
|
In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team includes in-depth expert analysis, import/export analysis, pricing analysis, production consumption analysis, and pestle analysis.
|
Segment Analysis:
The North America digital holographic microscopy in medical market is segmented on the basis of type, offering, process type, configuration, application and end user.
- On the basis of type, the North America digital holographic microscopy in medical market is segmented into label-free interferometric technique and quantitative phase image
- On the basis of offering, the North America digital holographic microscopy in medical market is segmented into hardware and software
- On the basis of process type, the North America digital holographic microscopy in medical market is segmented into digital recording and reconstruction
- On the basis of configuration, the North America digital holographic microscopy in medical market is segmented into gabor holography (inline holography), image plane holography, fresnel holography, fourier holography, and off-axis holography
- On the basis of application, the North America digital holographic microscopy in medical market is segmented into quantitative study of cellular dynamics, 3-D imaging, diabetics diagnosis, visualization of drug-induced morphology changes, resolve neuronal network activity, and others
- On the basis of end user, the North America digital holographic microscopy in medical market is segmented into hospitals and clinics, pharmaceutical and biotechnological companies, and academic medical centers and research organizations
Major Players
Data Bridge Market Research recognizes the following companies as the major North America digital holographic microscopy in medical market players in North America digital holographic microscopy in medical market are Geola (Lithuania), Holmarc Opto-Mechatronics Ltd. (India), Ovizio (Belgium), Realfiction (Sweden), ZEISS International (Germany), Jasper Display Corp.(U.S.), Trimos (Switzerland)
Market Developments
- In January 2023, augmented reality innovator ThirdEye launched a fully integrated thermal solution to its smart glasses lineup. This enhancement seamlessly combines human hologram images with an integrated thermal camera feed. The integration empowers doctors with real-time visual data during remote consultations, enabling more precise diagnoses and treatment recommendations, thereby advancing the efficacy of medical services through cutting-edge technology
- In November 2022, GigXR and ANIMA RES launched an integrated suite of holographic real-time 3D (RT3D) organ simulation models. Designed for medical education, these models enable students to observe virtual organs in different disease stages, offering precise insights into organ function and disease progression. This innovative tool enhances medical education by providing a realistic and immersive learning experience for aspiring healthcare professionals
- In December 2020, HÜBNER Photonics launched the Cobolt 05-iE, a fully integrated version of potent single-frequency lasers spanning 457 nm – 1064 nm. This addition to their product line enhances laser options for diverse applications, showcasing the company's commitment to advancing compact and powerful solutions across a broad wavelength spectrum for scientific and industrial uses
- In October 2020, Lyncee Tec expanded its product line with the launch of the EVOLUTIVE DHM T series microscope. This new model is designed to delve into physiopathological processes and assess cell health. The launch strengthens Lyncee Tec's digital holographic microscope portfolio, showcasing the company's commitment to advancing capabilities in exploring cellular dynamics and contributing to advancements in medical research and diagnostics
- In July 2020, Intelligent Imaging Innovations and Forth Dimension Displays (ForthDD), a Kopin Corporation subsidiary, extended their collaboration by launching 3i's Cleared Tissue LightSheet (CTLS). This product launch marked a significant expansion of 3i's product line, enhancing their offerings in the field of advanced imaging technologies and further solidifying the collaboration between Intelligent Imaging Innovations and Forth Dimension Displays
Regional Analysis
Geographically, the countries covered in the North America digital holographic microscopy in medical market report are U.S., Canada and Mexico in North America.
As per Data Bridge Market Research analysis:
U.S. is the dominant country in North America digital holographic microscopy in medical market during the forecast period 2022-2029
Os EUA dominam a microscopia holográfica digital norte-americana no mercado médico de imagens de fase quantitativa devido à crescente adoção de tecnologias de investigação avançadas. A proeminência da região decorre de uma adoção proativa de ferramentas de ponta, particularmente a microscopia holográfica, acentuando a sua liderança no avanço da investigação médica e do diagnóstico. A crescente prevalência destas tecnologias sublinha o papel fundamental dos EUA na formação do cenário de imagens de fase quantitativa no setor da saúde.
Estima-se que o México seja o país com o crescimento mais rápido na América do Norte em microscopia holográfica digital no mercado médico durante o período previsto de 2022-2029.
Espera-se que o México domine o mercado médico de microscopia holográfica digital na América do Norte, atribuindo a sua liderança à acessibilidade da tecnologia e aos avanços tecnológicos consistentes no país. O menor custo da microscopia holográfica digital, aliado às inovações contínuas, posiciona o México como um ator-chave, impulsionando o crescimento do mercado e a acessibilidade na investigação e diagnósticos médicos.
Para obter informações mais detalhadas sobre o relatório de mercado de microscopia holográfica digital na América do Norte, clique aqui – https://www.databridgemarketresearch.com/reports/north-america-digital-holographic-microscopy-in-medical-market
